Nigeria ‘unlikely to eliminate’ malaria by 2030 - Health group forecasts

Nigeria ‘unlikely to eliminate’ malaria by 2030 - Health group forecasts

- An international health body, Malaria Futures for Africa (MalaFa), has revealed that Nigeria will not be able to eliminate malaria in 20130

- In its reports MalaFa remarked that the number of malaria deaths was 445,000 in 2016, 438,000 in 2015

- It further said that malaria remains a major public health concern in Nigeria with about 76% of the population at risk

Malaria Futures for Africa (MalaFa), an international health organisation has said that Nigeria may not meet the 2030 target by Africa to eliminate malaria.

MalaFa said this in a statement issued in commemoration of the world malaria day, marked every April 25, with 2018's edition tagged Ready to Beat Malaria, The Cable reports.

READ ALSO: Breaking: Senate adjourns plenary to visit Dino Melaye in hospital

According to the 2017 world malaria report, there were 216 million cases of malaria in 2016, an increase on the 211 million cases recorded in 2015.

The number of malaria deaths was 445,000 in 2016, 438,000 in 2015. Ninety percent of malaria cases and over 90 percent of malaria deaths occur in sub-Saharan Africa. Infants under 5 years are particularly at risk, and malaria takes the life of a child every two minutes.

The MalaFa report said malaria remains a major public health issue in Nigeria with close to 76% of the population at endangered by the disease.

The report read: “Nigeria could eliminate malaria if there was political will. However, with the current way Nigeria is handling malaria, it is unlikely the country will be able to achieve malaria elimination by 2030.”

There are great plans, policies and documents but very little on the path of the government to make things work."

“Nigerians travel a lot with many traveling to Asia on business. This increases the prospects for importation of ACT-resistant parasite strains into the country.”

PAY ATTENTION: Get the Latest Nigerian News Anywhere 24/7. Spend less on the Internet!

According to the statement, throughout the next five years, Novartis, a pharmaceutical company, will invest more than $100 million to advance research and development of next-generation treatments to combat emerging resistance to artemisinin and other currently used antimalarials.

Meanwhile, reported that ahead of the Malaria Summit London 2018, co-hosted by the governments of Rwanda, Swaziland and the UK, the British government re-affirmed its commitment to spend £500 million a year on malaria through to 2020. gathered that leaders from donor and malaria-affected countries, governments, business, philanthropic and international organisations were coming together to reignite efforts to beat malaria.

Check out FOUR IMPORTANT ways to avoid contracting Typhoid fever - On TV


Mailfire view pixel